Oxygen Biotherapeutics Inc.(OXBT) reported a first-quarter net loss of $3.6 million, wider than $2.9 million in the prior year quarter. Loss per share for the latest first quarter was $0.22, narrower than $0.33 per share in the same quarter last year.
Net operating loss for the first quarter narrowed to $1.68 million from $2.43 million in the comparable quarter last year.
Total net revenue rose to $272,096 from $24,873 for the comparable quarter in the previous fiscal year.
Product revenue for the quarter decreased to $11,458 compared to $59,477 in the same quarter in 2011 primarily due to the reduction in our internal sales force and termination of existing distribution agreements in the prior year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.